Log in to save to my catalogue

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1561038001

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

About this item

Full title

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

Publisher

Kidlington: Elsevier Ltd

Journal title

The Lancet (British edition), 2014-06, Vol.383 (9933), p.2008-2017

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Few trials of glucose-lowering drugs or strategies in people with type 2 diabetes have investigated cardiovascular outcomes, even though most patients die from cardiovascular causes despite the beneficial effects of lipid-reducing and blood pressure-lowering treatments. The evidence-based reduction in risk of microvascular disease with gluc...

Alternative Titles

Full title

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1561038001

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1561038001

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(14)60794-7

How to access this item